![Ari VanderWalde](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ari VanderWalde
Direttore Tecnico/Scientifico/R&S presso Vector Oncology Solutions LLC
Posizioni attive di Ari VanderWalde
Società | Posizione | Inizio |
---|---|---|
Vector Oncology Solutions LLC
![]() Vector Oncology Solutions LLC Investment ManagersFinance Founded in 2001 by John McFarland, Vector Oncology Solutions LLC is a leader of oncology specific biopharmaceutical development and commercial outsourcing services. The firm was formerly known as Acorn Research LLC and is located in Memphis, Tennessee. Their novel data repository comprised of aggregated clinical (EMR), patient reported outcomes, genomic, physician notes and billing data powers a broad array of retrospective and prospective HEOR projects that provide an understanding of current practices in oncology care. Vector Oncology also provides comprehensive clinical trial services with specific expertise in supporting and accelerating early phase clinical trials and providing real-world late stage services. | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Vector Oncology Solutions LLC
![]() Vector Oncology Solutions LLC Investment ManagersFinance Founded in 2001 by John McFarland, Vector Oncology Solutions LLC is a leader of oncology specific biopharmaceutical development and commercial outsourcing services. The firm was formerly known as Acorn Research LLC and is located in Memphis, Tennessee. Their novel data repository comprised of aggregated clinical (EMR), patient reported outcomes, genomic, physician notes and billing data powers a broad array of retrospective and prospective HEOR projects that provide an understanding of current practices in oncology care. Vector Oncology also provides comprehensive clinical trial services with specific expertise in supporting and accelerating early phase clinical trials and providing real-world late stage services. | Finance |
- Borsa valori
- Insiders
- Ari VanderWalde